Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study

被引：0
|
作者：
Piero Barbanti
Cinzia Aurilia
Gabriella Egeo
Stefania Proietti
Florindo D’Onofrio
Paola Torelli
Marco Aguggia
Davide Bertuzzo
Cinzia Finocchi
Michele Trimboli
Sabina Cevoli
Giulia Fiorentini
Bianca Orlando
Maurizio Zucco
Laura Di Clemente
Ilaria Cetta
Bruno Colombo
Monica Laura Bandettini di Poggio
Valentina Favoni
Licia Grazzi
Antonio Salerno
Antonio Carnevale
Micaela Robotti
Fabio Frediani
Claudia Altamura
Massimo Filippi
Fabrizio Vernieri
Stefano Bonassi
机构：
[1] IRCCS San Raffaele Roma,Headache and Pain Unit
[2] San Raffaele University,Clinical and Molecular Epidemiology
[3] IRCCS San Raffaele Roma,Headache Center Neurology Unit
[4] San Giuseppe Moscati Hospital,Unit of Neurology, Department of Medicine and Surgery, Headache Center
[5] University of Parma,Headache Center
[6] Headache Center Cardinal Massaia,Neurology Unit, IRCCS San Raffaele Scientific Institute
[7] Divisione di Neurologia,Neuroalgology Unit, Headache Center Fondazione
[8] University Magna Graecia,Headache Center
[9] IRCCS Istituto delle Scienze Neurologiche di Bologna,Headache and Neurosonology Unit
[10] San Camillo-Forlanini Hospital,undefined
[11] Vita-Salute San Raffaele University,undefined
[12] IRCCS Ospedale Policlinico San Martino,undefined
[13] IRCCS Istituto Neurologico“Carlo Besta”,undefined
[14] Headache Center San Giovanni Addolorata Hospital,undefined
[15] Headache Center San Filippo Neri Hospital,undefined
[16] ASST Santi Paolo Carlo,undefined
[17] Policlinico Universitario Campus Bio-Medico,undefined
来源：
Journal of Neurology | 2024年 / 271卷
关键词：
Migraine; Treatment; Anti-CGRP mAbs; Responder; Late response; Ultra-late response; Real-life;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2434 / 2443
页数：9
相关论文
共 50 条
  • [41] Effectiveness and safety of anti-CGRP monoclonal antibodies for migraine in patients over 65 years: a systematic review
    Munoz-Vendrell, Albert
    Lopez-Bravo, Alba
    Layos-Romero, Almudena
    Alberola-Amores, Francisco J.
    Caballero, Maria Obdulia Lozano
    Sanchez-Soblechero, Antonio
    Morales-Hernandez, Cristian
    Castro-Sanchez, Maria Victoria
    Navarro-Perez, Maria Pilar
    Cordova-Infantes, Maria Rocio
    Caronna, Edoardo
    Irimia, Pablo
    Gonzalez-Martinez, Alicia
    Jr Headache Grp Spanish Soc Neurology jGECSEN
    PAIN MANAGEMENT, 2025, 15 (03) : 161 - 171
  • [42] Efficacy and Safety of Anti-CGRP Monoclonal Antibodies in Prevention of Chronic Migraine: A Bayesian Network Meta-analysis
    Haridas, Mundot Puliappadamb
    Tripathy, Amruta
    Maiti, Rituparna
    Srinivasan, Anand
    CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2024, 22 (01) : 23 - 32
  • [43] Meta-regression to explain the placebo effects in clinical trials of anti-CGRP monoclonal antibodies for migraine prevention
    Regnier, Stephane Alexandre
    Lee, Xin Ying
    JOURNAL OF MEDICAL ECONOMICS, 2023, 26 (01) : 1072 - 1080
  • [44] Monoclonal anti-CGRP antibodies in post-menopausal women: a real-life study
    Simona, Guerzoni
    Carlo, Baraldi
    Daria, Brovia
    Michela, Cainazzo Maria
    Flavia, Lo Castro
    Luca, Pani
    ACTA NEUROLOGICA BELGICA, 2023, 123 (03) : 1039 - 1047
  • [45] Safety of anti-CGRP monoclonal antibodies in patients with migraine during the COVID-19 pandemic: Present and future implications
    Caronna, E.
    Jose Gallardo, V
    Alpuente, A.
    Torres-Ferrus, M.
    Sanchez-Mateo, N. M.
    Viguera-Romero, J.
    Lopez-Veloso, A. C.
    Lopez-Bravo, A.
    Gago-Veiga, A. B.
    Irimia Sieira, P.
    Porta-Etessam, J.
    Santos-Lasaosa, S.
    Pozo-Rosich, P.
    NEUROLOGIA, 2021, 36 (08): : 611 - 617
  • [46] Outcomes, unmet needs, and challenges in the management of patients who withdraw from anti-CGRP monoclonal antibodies: A prospective cohort study
    Burgalassi, Andrea
    Romozzi, Marina
    Vigani, Giulia
    De Icco, Roberto
    Raffaelli, Bianca
    Boccalini, Alberto
    De Cesaris, Francesco
    Calabresi, Paolo
    Geppetti, Pierangelo
    Chiarugi, Alberto
    Iannone, Luigi Francesco
    CEPHALALGIA, 2024, 44 (11)
  • [47] Monoclonal anti-CGRP antibodies in post-menopausal women: a real-life study
    Simona Guerzoni
    Carlo Baraldi
    Daria Brovia
    Maria Michela Cainazzo
    Flavia Lo Castro
    Luca Pani
    Acta Neurologica Belgica, 2023, 123 : 1039 - 1047
  • [48] Evaluation of the risk of hypertension in patients treated with anti-CGRP monoclonal antibodies in a real-life study
    Simona Guerzoni
    Flavia Lo Castro
    Daria Brovia
    Carlo Baraldi
    Luca Pani
    Neurological Sciences, 2024, 45 : 1661 - 1668
  • [49] Evaluation of the risk of hypertension in patients treated with anti-CGRP monoclonal antibodies in a real-life study
    Guerzoni, Simona
    Castro, Flavia Lo
    Brovia, Daria
    Baraldi, Carlo
    Pani, Luca
    NEUROLOGICAL SCIENCES, 2024, 45 (04) : 1661 - 1668
  • [50] Predicting response to CGRP-monoclonal antibodies in patients with migraine in Japan: a single-centre retrospective observational study
    Ihara, Keiko
    Ohtani, Seiya
    Watanabe, Narumi
    Takahashi, Nobuyuki
    Miyazaki, Naoki
    Ishizuchi, Kei
    Hori, Satoko
    Takemura, Ryo
    Nakahara, Jin
    Takizawa, Tsubasa
    JOURNAL OF HEADACHE AND PAIN, 2023, 24 (01)
12345